SCRIPTIV Trademark

Trademark Overview


On Monday, February 14, 2022, a trademark application was filed for SCRIPTIV with the United States Patent and Trademark Office. The USPTO has given the SCRIPTIV trademark a serial number of 97266426. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, July 30, 2024. This trademark is owned by Astellas Pharma Inc.. The SCRIPTIV trademark is filed in the Computer & Software Products & Electrical & Scientific Products category with the following description:

Downloadable computer application software for use with web-based platforms and mobile devices in the nature of tablet computers, personal digital assistants (PDAs) and mobile phones, namely, downloadable software for use in accessing a patient's implanted medical device data and transmitting information in the nature of diagnosis of disease, the self-management of symptoms and disabilities, the real-time monitoring of physical and biological indicators, the management of complex medication regimens in order to maintain proper levels of nutrition, diet or exercise which embodies a patient-centric approach for early disease detection whilst aiding and fostering a closer interaction between patients and healthcare providers
scriptiv

General Information


Serial Number97266426
Word MarkSCRIPTIV
Filing DateMonday, February 14, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements


Goods and ServicesDownloadable computer application software for use with web-based platforms and mobile devices in the nature of tablet computers, personal digital assistants (PDAs) and mobile phones, namely, downloadable software for use in accessing a patient's implanted medical device data and transmitting information in the nature of diagnosis of disease, the self-management of symptoms and disabilities, the real-time monitoring of physical and biological indicators, the management of complex medication regimens in order to maintain proper levels of nutrition, diet or exercise which embodies a patient-centric approach for early disease detection whilst aiding and fostering a closer interaction between patients and healthcare providers
Pseudo MarkSCRIPT IV

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, February 18, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Trademark Events


Event DateEvent Description
Tuesday, November 29, 2022ASSIGNED TO EXAMINER
Thursday, February 17, 2022NEW APPLICATION ENTERED
Friday, February 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 2, 2022NON-FINAL ACTION WRITTEN
Friday, December 2, 2022NON-FINAL ACTION E-MAILED
Friday, December 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 15, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024SOU EXTENSION 1 FILED
Wednesday, January 17, 2024SOU EXTENSION 1 GRANTED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, July 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2024SOU EXTENSION 2 GRANTED
Tuesday, July 30, 2024SOU EXTENSION 2 FILED